جست‌وجوی استاد و پژوهشگر

Stefan Dumaمشاهده پروفایل

استاد

• Biomechanics
• Injury Biomechanics
• Impact Biomechanics
• +۷ مورد دیگر

Stefan Duma is the Harry C. Wyatt Professor of Engineering and a University Distinguished Professor at Virginia Tech. He is currently serving as Interim Department Head in the Department of Biomedical Engineering and Mechanics within the College of Engineering. He also directs the Institute for Critical Technology and Applied Sciences and leads the Virginia Tech Helmet Lab. His educational background includes: Ph.D. in Mechanical Engineering from the University of Virginia (2000) M.S. in Industrial Engineering from the University of Cincinnati (1996) B.S. in Mechanical Engineering from the University of Tennessee (1995) Dr. Duma's research focuses on injury and impact biomechanics, with applications in automobile safety design , sports biomechanics (especially football and hockey), and military restraint systems . His work investigates head and neck injury mechanisms, concussion thresholds, and protective equipment performance. He has pioneered methodologies for evaluating helmet safety and individualized injury tolerance. The recent publications reflect a strong focus on head impact biomechanics , concussion prediction , and wearable sensor validation . The research spans youth and collegiate sports, drone impact risks, and automotive safety. Key themes include individual variability in injury response, helmet performance assessment, and translational safety applications. Scientific recognition includes his appointment as a University Distinguished Professor and leadership roles, though specific awards are not listed in the provided text. Dr. Duma advises a team of researchers and students, including Steven Rowson, Abigail Tyson, and Eamon Campolettano. His lab has secured significant research funding (implied by patent and publication volume), particularly in developing safety standards and injury prevention technologies. The Virginia Tech Helmet Lab is central to his research, conducting experiments with human volunteers, PMHS, and advanced instrumentation. His lab, the Virginia Tech Helmet Lab, is a leading center for impact biomechanics research, focusing on real-world safety challenges in sports, transportation, and emerging technologies like drones.

Michael J. Spiveyمشاهده پروفایل

استاد

• Psycholinguistics
• Visual Perception
• Sensorimotor Processing
• +۵ مورد دیگر

Michael J. Spivey is a Professor of Cognitive Science at the University of California, Merced, affiliated with the School of Social Sciences, Humanities and Arts. His research focuses on understanding human cognition through embodied and dynamic systems approaches, with particular expertise in eye-tracking methodologies and real-time language processing. As a faculty member in the Cognitive and Information Sciences department, he contributes to interdisciplinary research that bridges psychology, linguistics, and neuroscience. Dr. Spivey's educational background includes: Ph.D. in Brain and Cognitive Sciences from the University of Rochester (1996) M.A. in Brain and Cognitive Sciences from the University of Rochester (1995) B.A. from the University of California, Santa Cruz (1991) His research interests span psycholinguistics, visual perception, sensorimotor processing, embodied cognition, and dynamical systems theory. Dr. Spivey investigates how cognitive processes unfold in real-time through eye movements and other behavioral measures, challenging traditional modular views of cognition. His work emphasizes the continuous interaction between perception, action, and cognition, demonstrating how language processing is deeply embedded in our sensorimotor experiences. He has made significant contributions to understanding the time course of language comprehension, the role of visual context in linguistic processing, and the dynamic nature of cognitive representations. Analysis of Dr. Spivey's recent publications reveals a strong focus on embodied and dynamic approaches to cognition. His work spans diverse areas including eye-tracking and mouse-tracking methodologies, team cognition, creativity research, bilingual language processing, and the application of foraging theory to cognitive processes. A recurring theme across these publications is the investigation of real-time cognitive dynamics using continuous behavioral measures. His research increasingly incorporates ecological approaches, examining cognition in more naturalistic contexts while maintaining experimental rigor. The interdisciplinary nature of his work is evident in collaborations across psychology, linguistics, neuroscience, and even music cognition. Dr. Spivey is affiliated with the Center for Human Adaptive Systems and Environments and collaborates with researchers at Western University, Northwestern University, Brown University, and UCLA. His work with students likely focuses on training in advanced methodologies for measuring real-time cognitive processes.

Pavel P. Kuksaمشاهده پروفایل

عضو هیئت علمی

• Bioinformatics
• Computer Science
• Functional Genomics
• +۵ مورد دیگر

Pavel P. Kuksa is a Research Assistant Professor in the Department of Pathology and Laboratory Medicine, specializing in bioinformatics, computer science, and functional genomics. His work focuses on high-throughput sequencing analysis, chromatin interaction data, and developing scalable software platforms for genomics research.

Leanna Hernandezمشاهده پروفایل

استادیار

• Neuroimaging in Autism Spectrum Disorders
• Genetics of Psychiatric Disorders
• Sex Differences in Brain Development
• +۵ مورد دیگر

Leanna Hernandez, Ph.D., is Assistant Professor-in-Residence in the Department of Psychiatry and Biobehavioral Sciences at the David Geffen School of Medicine, University of California, Los Angeles. She directs the Hernandez Lab and can be reached at leannahernandez@ucla.edu . Her research integrates multimodal neuroimaging with large-scale genetics to uncover mechanisms underlying autism spectrum disorders, sex differences in brain development, and the role of immune–neurodevelopment pathways such as the complement system. Core themes include: Mapping how common genetic variation shapes brain structure and function across development. Identifying neural signatures that explain the female protective effect in ASD. Elucidating interactions between sleep physiology and brain maturation in youth. Across more than 40 peer-reviewed publications (2012-2023) she has leveraged data from the Adolescent Brain Cognitive Development (ABCD) Study, the GENDAAR Consortium, and multiple international biobanks, generating insights into white-matter microstructure, functional connectivity, and transcriptomic correlates of psychiatric traits. Scientific collaborations span UCLA, UC San Diego, University of Queensland, and the Busselton Health Study, reflecting an interdisciplinary approach that combines neuroimaging, genomics, lipidomics, and behavioral phenotyping. Dr. Hernandez’s laboratory website ( hernandezlabucla.org ) provides further resources, although specific trainees, grants, and awards are not detailed in the supplied text.

• Neurodegenerative Diseases
• Alzheimer's Disease
• Parkinson's Disease
• +۱۲ مورد دیگر

Frédéric Calon is a Full Professor in the Faculty of Pharmacy at Université Laval, where he leads a prominent research program focused on neurodegenerative disorders, particularly Alzheimer’s and Parkinson’s diseases. His work bridges molecular neuroscience, nutritional interventions, and blood-brain barrier drug delivery, using both animal models and human post-mortem studies. He is actively involved in training graduate students and postdoctoral fellows and maintains international collaborations, including the LIA OptiNutriBrain with Bordeaux. B.Sc. in Biochemistry, Université Laval (1989–1992) M.Sc. in Pharmacy, Université Laval (1992–1995) B.Pharm., Université Laval (1994–1998) Ph.D. in Pharmacy, Université Laval (1998–2001) Postdoctoral Training, University of California, Los Angeles (UCLA), Dept. of Medicine (2001–2003) Dr. Calon’s research centers on three main axes: (1) the role of nutrition—especially omega-3 fatty acids—in neurodegeneration; (2) synaptic and molecular pathology in Alzheimer’s and Parkinson’s diseases; and (3) the interplay between peripheral metabolic disorders and brain health, including insulin signaling and thermoregulation. He also investigates the blood-brain barrier as a therapeutic gateway for drug delivery. His recent publications reflect a strong focus on Alzheimer’s disease mechanisms, including tau phosphorylation, amyloid-beta pathology, synaptic dysfunction, and the impact of diet and metabolism. He has also made key contributions to understanding essential tremor through post-mortem brain studies. His work frequently involves transgenic mouse models, such as the 3xTg-AD, and integrates behavioral, biochemical, and imaging techniques. Dr. Calon’s research is supported by major grants from CIHR and the Alzheimer Society of Canada. He mentors a large team of doctoral, master’s, and postdoctoral researchers, many of whom are supported by competitive scholarships. His lab has developed unique expertise in in situ brain perfusion and quantitative BBB transport analysis. He leads studies on novel therapeutic strategies, including repurposing beta-3 adrenergic agonists, optimizing nutraceutical formulations, and enhancing brain delivery of biologics via transferrin receptor-targeted vectors. His work on essential tremor has identified GABA receptor deficits and amyloid-beta accumulation in the cerebellum, suggesting a neurodegenerative basis for the disorder.

Wilfried O. Rossollمشاهده پروفایل

دانشیار

• Neurodegenerative Diseases
• Protein Aggregation
• Neuroproteomics
• +۱۳ مورد دیگر

Wilfried O. Rossoll, Ph.D., is an Associate Professor of Neuroscience at Mayo Clinic in Jacksonville, Florida, and serves as Assistant Dean at the Mayo Clinic Graduate School of Biomedical Sciences. He leads the Translational Neuroproteomics Laboratory and is Director of the Multi-Omics Mass Spectrometry Core Laboratory. His research focuses on the molecular mechanisms of protein aggregation in neurodegenerative diseases such as ALS, frontotemporal dementia, and Alzheimer's disease. Ph.D., University of Vienna, Austria Master of Science, University of Vienna, Austria (with research at IMP) Dr. Rossoll's research interests center on understanding proteinopathies—diseases defined by abnormal aggregation of proteins like TDP-43 and tau. His lab uses advanced proteomics, mass spectrometry, and fluorescence microscopy to analyze neuropathological aggregates in human brain tissue and disease models. Key areas include spatial proteomics, molecular profiling of aggregates, mechanisms of protein misfolding, and identifying therapeutic modifiers of aggregation. His work bridges basic science and translational applications, aiming to develop novel therapies for neurodegenerative disorders. The recent publications highlight a strong focus on TDP-43 and tau pathology, phase transitions, stress granule dynamics, and the discovery of nuclear import receptors and other modifiers as therapeutic targets. Techniques such as proximity labeling and spatial proteomics are central to uncovering disease mechanisms and biomarkers. Standing member, Cellular and Molecular Biology of Neurodegeneration Study Section, NIH (2024–present) Associate Editor, Molecular Neurodegeneration (2020–present) Dr. Rossoll has secured multiple research grants from the National Institute on Aging and the U.S. Army, serving as Principal Investigator on projects related to TDP-43 and tau pathology, neuron-glia interactions in Alzheimer's disease, and development of CNTF receptor agonists for ALS therapy. He has mentored postdoctoral fellows and graduate students, contributing to training in neuroscience and proteomics. His laboratory collaborates extensively with the Mayo Clinic Brain Bank and neuropathology teams to validate findings in human tissues. The Translational Neuroproteomics Laboratory operates at the intersection of molecular neuroscience and proteomics, utilizing cutting-edge technologies to decode the composition and dynamics of pathological aggregates. The lab’s work is integral to Mayo Clinic’s broader research mission in neurodegenerative diseases, with a strong emphasis on translating discoveries into clinical applications.

Yasser Iturria Medinaمشاهده پروفایل

استادیار

• Neuroimaging
• Neuroinformatics
• Precision Medicine
• +۶ مورد دیگر

Yasser Iturria Medina is an Assistant Professor at the Montreal Neurological Institute (MNI) , McGill University, within the Department of Neurology and Neurosurgery . He is an associate member of the Ludmer Centre for Neuroinformatics and Mental Health and the McConnell Brain Imaging Centre . Academic Rank: Assistant Professor Key Affiliations: MNI, Ludmer Centre, McConnell Brain Imaging Centre His educational background includes: Undergraduate: Nuclear Engineering (2004), Higher Institute for Nuclear Sciences and Technology, Cuba MSc: Neurophysics and Neuroengineering (2006), Cuban Neuroscience Center PhD: Neuroimaging and Neuroinformatics (2013), National Center for Scientific Research and Havana’s University of Medical Science His research focuses on neuroinformatics for precision medicine , particularly in neurodegenerative diseases like Alzheimer's and Parkinson's. His lab develops multiscale brain models integrating molecular, imaging, and cognitive data to characterize pathogenic mechanisms and identify personalized interventions. Key research areas include: Neurodegeneration modeling Neurovascular interactions in Alzheimer's Multi-omics integration for disease subtyping Neuroimaging biomarkers across neurodegenerative spectra Computational modeling of amyloid-beta and tau propagation The article analysis reveals his emphasis on: Alzheimer's disease mechanisms (45% of recent works) Multi-omics and transcriptomic modeling (30%) Neurovascular and white matter pathology (20%) Machine learning applications in neuroimaging (15%) Development of tools like NeuroPM-box and MVComp toolbox His lab has been instrumental in creating NeuroPM-box , a software platform for integrating molecular, neuroimaging, and clinical data to characterize neurodegenerative progression and heterogeneity. He has also contributed to CAPTURE ALS , a comprehensive analysis platform for amyotrophic lateral sclerosis.

Kevin Langergraberمشاهده پروفایل

دانشیار

• Primate Behavior
• Conservation Biology
• Genetics
• +۳ مورد دیگر

Dr. Kevin Langergraber is an Associate Professor at Arizona State University's School of Human Evolution and Social Change. His research focuses on primate behavior, conservation biology, and evolutionary anthropology, particularly through his leadership in the Ngogo Chimpanzee Project in Uganda's Kibale National Park. This long-term study examines chimpanzee social structures, health dynamics, and ecological interactions, with a strong emphasis on conservation strategies against poaching and disease transmission. Key research interests include genetic adaptation in primates, the impact of human activities on wildlife communities, and behavioral ecology across varying environmental conditions. He has pioneered methods combining genomic analysis, field observations, and machine learning to study ape behavior and biodiversity monitoring. His work integrates socioecological data with physiological measurements to understand aging patterns, reproductive strategies, and disease epidemiology in wild populations. Recent publications highlight advancements in wildlife conservation protocols, primate menopause studies, and innovative datasets for behavior recognition. Collaborations span global institutions to address challenges in primate conservation and evolutionary biology. Dr. Langergraber also engages in public outreach through documentaries and crowdfunding initiatives to fund anti-poaching patrols and support chimpanzee research.

• Dementia
• Motor Neuron Disease
• Neurosciences
• +۳ مورد دیگر

Associate Professor Rachel Tan is an academic affiliated with the University of Sydney's School of Medical Sciences (Neuroscience), and a member of The Centre for Drug Discovery Innovation and the Brain and Mind Centre. Her research focuses on neurodegenerative diseases including dementia, motor neuron disease, and nervous system disorders, with an emphasis on pathogenesis, translational research, and proteinopathies like TDP-43 and tauopathies. She has contributed to over 50 peer-reviewed publications since 2012, exploring topics such as ALS-FTD clinical-pathologic overlaps, biomarker development, and therapeutic strategies. Her work frequently involves post-mortem neuropathological studies and correlates clinical phenotypes with molecular pathology. Education and Affiliations University of Sydney - School of Medical Sciences Affiliated with Brain and Mind Centre and Centre for Drug Discovery Innovation Research Interests Frontotemporal dementia (FTD) and ALS clinical-pathologic subtypes TDP-43 and tau protein aggregation mechanisms Neurodegenerative disease biomarkers Neuropathological classification systems Motor neuron disease therapeutics Recent Article Trends Her 2023-2024 work emphasizes ALS drug efficacy evaluations (e.g., riluzole effects), survival biomarkers (p62 spinal cord burden), and dementia policy in the Western Pacific region. Earlier studies (2017-2019) revealed insights into dual pathologies (Lewy body coexistence with ALS/FTD) and genetic heritability in PPA-ALS subtypes. Translational research includes CuATSM copper compound trials and cerebellar atrophy meta-analyses. Grants and Funding FightMND Mid-Career Research Fellowship (2023) Motor Neurone Disease Research Institute of Australia grants (2023, 2019) NHMRC Dementia Research Fellowships (2015) Labs/Teams Collaborates with multidisciplinary teams at the Brain and Mind Centre, focusing on neurodegenerative disease mechanisms and precision medicine initiatives targeting TDP-43 pathobiology.

• Magnetic Resonance Imaging (MRI)
• Neuroimaging Biophysics
• Brain Metabolism Analysis
• +۶ مورد دیگر

Harald E. Möller is a Professor and Head of the Nuclear Magnetic Resonance Research and Development Unit at the Max Planck Institute for Human Cognitive and Brain Sciences in Leipzig. With a career spanning over four decades, he has held academic positions including Honorary Professor at the University of Leipzig and leadership roles in institutions like Duke University Medical Center and the University of Münster. His research focuses on advancing MRI methodologies, biophysical imaging principles, and their applications in neurology and neuroscience. Education: 1979-1985: Chemistry & Physics studies at Universities of Dortmund and Münster 1985: M.Sc. (Diploma) in Chemistry 1988: PhD in Physical Chemistry (summa cum laude) 2000: Habilitation in Physical Chemistry 2002: Habilitation in Biophysical Chemistry Research Interests: Development of novel MRI methods Quantitative tissue characterization Myelin sheath imaging Cerebral blood flow dynamics High-field MRI hardware

Sabine Bahnمشاهده پروفایل

استاد

• Neuropsychiatric Disorders
• Proteomics
• Biomarker Discovery
• +۴ مورد دیگر

Professor Sabine Bahn is a practising psychiatrist, Chair in Neurotechnology, and Director of the Cambridge Centre for Neuropsychiatric Research at the University of Cambridge. She is also a Fellow of Lucy Cavendish College. Royal College of Psychiatrists British Medical Association American Neuroscience Association British Neuroscience Association British Association of Psychopharmacology World Federation of Societies of Biological Psychiatry Royal Society of Biology Research Interests: Sabine Bahn's work focuses on the molecular basis of neuropsychiatric disorders such as schizophrenia and mood disorders. She develops novel diagnostics and therapeutics, integrating neurotechnology and proteomics for biomarker discovery. Her research has led to the co-founding of two spin-out companies: Psynova Neurotech Ltd. (2005), which launched the first blood test for schizophrenia diagnosis, and PsyOmics Ltd. (2015), combining digital tools and blood-based biomarkers for mental health disorders like bipolar disorder and depression. Scientific Contributions: She has published over 180 high-impact articles, emphasizing proteomics and gene expression in psychiatric disorders. Her recent work includes CSF metabolic profiling , label-free LC-MSMS , and peptide correlation methods for biomarker validation. Professional Affiliations: She is actively involved in professional bodies such as the Royal College of Psychiatrists, British Neuroscience Association, and the Royal Society of Biology.

Andrea Schmittمشاهده پروفایل

استاد

• Neurobiology
• Schizophrenia
• Post-mortem studies
• +۳ مورد دیگر

Andrea Schmitt is a Professor at the Ludwig Maximilian University of Munich, affiliated with the Clinic for Psychiatry and Psychotherapy. She is a regular member of the Munich Clinic Network (MCN) and focuses on the neurobiology of schizophrenia. University: Ludwig Maximilian University of Munich Department: Clinic for Psychiatry and Psychotherapy Academic Rank: Professor Her research integrates post-mortem studies, animal models, and gene expression analysis to explore schizophrenia's structural and molecular underpinnings. Recent work examines synaptic elements and immune-modulatory genes in the temporal cortex. The selected publications span 2008–2012, emphasizing stereology, neuroimaging, and molecular neuroscience. These studies investigate brain connectivity, synaptic dysfunction, and immune interactions in schizophrenia, utilizing post-mortem and preclinical models. Contact: Email | Phone: +49 (0)89 / 4400-53371 | Website: LMU Psychiatry Staff

Ramon Velazquezمشاهده پروفایل

استادیار

• Neurodegenerative Diseases
• Alzheimer's Disease
• Down Syndrome
• +۵ مورد دیگر

Ramon Velazquez is an Assistant Professor at the Arizona State University (ASU) School of Life Sciences and a member of the ASU-Banner Neurodegenerative Disease Research Center . His research focuses on identifying pathogenic mechanisms in neurodegenerative diseases, particularly Alzheimer’s and Down Syndrome, and developing therapeutic strategies. He is also the director of the Workforce Inclusion in Neuroscience through Undergraduate Research Experience (WINURE) program. Velazquez holds a PhD in Neuroscience from Cornell University (2014) and completed a postdoc at ASU, funded by National Science Foundation (NSF) fellowships. He has secured grants from NIH and serves on the NIH Chronic Dysfunction and Integrative Neurodegeneration (CDIN) study section. His lab employs mouse models (e.g., Ts65Dn, APP/PS1) and post-mortem human brain tissue to study neurodegenerative processes. Research interests include environmental factors in neurodegeneration, choline supplementation’s therapeutic potential, and the intersection of Down Syndrome and Alzheimer’s pathology. He has mentored numerous students and collaborates widely, emphasizing interdisciplinary approaches and workforce diversity in neuroscience. Velazquez has received awards such as the Alzheimer’s Drug Discovery Foundation Young Investigator Scholar (2017) and has published extensively on topics like glyphosate’s neurotoxic effects, tau pathology, and microglial mechanisms.

Casey N. Cookمشاهده پروفایل

دانشیار

• Neurodegenerative Diseases
• Alzheimer's Disease
• Tauopathy
• +۱۲ مورد دیگر

Dr. Casey N. Cook is an Associate Professor of Neuroscience at Mayo Clinic in Jacksonville, Florida, where she leads the Comparative Pathogenesis of Alzheimer's Disease and Related Disorders Laboratory. Her research is dedicated to uncovering the molecular mechanisms underlying neurodegenerative diseases, with a strong focus on tauopathies, TDP-43 proteinopathies, and white matter abnormalities. Her research interests include: Pathogenic mechanisms in tau aggregation and toxicity TDP-43 pathology in Alzheimer’s disease, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS) Role of oligodendrocytes and myelination defects in neurodegeneration Utilization of animal and cellular models to validate findings in human tissue Dr. Cook’s recent publications reflect a strong trend in structural and molecular neuroscience, particularly in protein aggregation diseases. Her work leverages cryo-EM, transgenic models, and human biofluid/tissue analysis to identify therapeutic targets and biomarkers. She is actively involved in high-impact collaborative research across neurodegenerative disorders. Her scientific contributions are supported by multiple NIH grants, including those from the National Institute on Aging and the National Institute of Neurological Disorders and Stroke. Notable projects include: Investigating tau and ApoE4-mediated alterations in oligodendrocyte progenitor cells Impact of T cells on the CNS during aging and Alzheimer’s disease Mechanistic insights into the A152T risk variant and tauopathy Manipulating tau's posttranslational modifications to block disease progression Dr. Cook collaborates extensively with leading researchers at Mayo Clinic, including Dr. Petrucelli, Dr. Dickson, and Dr. Kang. Her laboratory is part of Mayo Clinic’s robust neuroscience research ecosystem, contributing to both discovery and translational efforts in neurodegenerative diseases.

Matt Havrdaمشاهده پروفایل

دانشیار

• Neurodegenerative Diseases
• Parkinson's Disease
• Neuroinflammation
• +۶ مورد دیگر

Matt Havrda is an Associate Professor in Biomedical Sciences and Associate Dean for Research and Scholarship at the University of New England College of Osteopathic Medicine. He earned his Ph.D. from the Graduate School of Biomedical Science and Engineering at the University of Maine and leads a research program focused on the molecular basis of Parkinson’s disease and neuroinflammation. Research Interests: Dr. Havrda's work centers on understanding how environmental exposures interact with the innate immune system to drive neurodegeneration, particularly in Parkinson’s disease. His research integrates molecular biology, immunology, and translational neuroscience, using cellular and animal models as well as patient-derived biofluids and post-mortem tissues. Key areas include NLRP3 inflammasome signaling, epigenetic regulation via DNA methylation, and identification of early biomarkers for disease progression. Publication Trends: His recent publications demonstrate a consistent focus on neuroinflammation, inflammasome activation, and gene-environment interactions in Parkinson’s disease. The studies utilize longitudinal human data, genetic models, and environmental toxin exposures to uncover mechanisms of disease and potential therapeutic targets. Scientific Awards: Ruth L. Kirschstein National Research Service Award (NINDS) Dartmouth SYNERGY Scholar Award for Clinical and Translational Research Target Validation Award from the Michael J. Fox Foundation Advising and Grants: While specific advisees are not listed, Dr. Havrda leads an active research laboratory. His work is currently supported by the National Institute for Environmental Health Sciences, indicating sustained federal funding for his investigations into environmental impacts on neurological disorders. Labs and Teams: Dr. Havrda collaborates extensively with interdisciplinary teams, including epidemiologists, immunologists, and neuroscientists. His lab employs cutting-edge techniques in molecular biology and epigenetics to study neurodegeneration, contributing to both basic science and clinical translation in Parkinson’s disease research.